HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 322 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $207 | -100.0% | 5,602 | -69.7% | 0.46% | -18.6% |
| Q3 2021 | $496,000 | +740.7% | 18,496 | +1332.7% | 0.57% | +848.3% |
| Q2 2021 | $59,000 | -52.4% | 1,291 | -56.5% | 0.06% | -55.9% |
| Q1 2021 | $124,000 | -63.5% | 2,966 | -62.7% | 0.14% | -64.1% |
| Q4 2020 | $340,000 | +45.9% | 7,952 | -10.6% | 0.38% | +60.6% |
| Q3 2020 | $233,000 | -88.0% | 8,895 | -91.3% | 0.24% | -67.8% |
| Q2 2020 | $1,939,000 | +6586.2% | 102,462 | +6336.1% | 0.73% | +1459.6% |
| Q1 2020 | $29,000 | -92.4% | 1,592 | -93.1% | 0.05% | -81.1% |
| Q3 2019 | $381,000 | -73.6% | 23,093 | -72.5% | 0.25% | -69.4% |
| Q2 2019 | $1,443,000 | – | 83,966 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |